PMC3420792_01
PMC3420792_02
PMC3420792_03
Bone marrow aspirate (x1000, panoptical staining) from the time of diagnosis; monocyte population (atypical monocytes, promonocytes). The finding was classified as CMML-2 (16% of myeloblasts).
CRIM.HEMATOLOGY2012-369086.001.jpg
PMC3420792_03_CRIM.HEMATOLOGY2012-369086.001.jpg
fig1
AZA cycles. After 13 AZA cycles a progression to AML was described in the control bone marrow aspirate (Figures 1 and 2).
Bone marrow aspirate (x1000, panoptical staining) after 13 AZA cycles; myeloblasts and monoblasts, progression to AML (60% of myeloblasts).
CRIM.HEMATOLOGY2012-369086.002.jpg
PMC3420792_03_CRIM.HEMATOLOGY2012-369086.002.jpg
fig2
AZA cycles. After 13 AZA cycles a progression to AML was described in the control bone marrow aspirate (Figures 1 and 2).